Clinical Trials Directory

Trials / Sponsors / Xentria, Inc.

Xentria, Inc.

Industry · 8 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
CompletedStudy to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(L), US-Humalog®, and EU-Hu
Healthy Male Adult Volunteers
Phase 12025-10-13
WithdrawnStudy to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus
Osteoporosis
Phase 32025-10-01
CompletedStudy to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS Glargine (G), United State
Healthy Participants
Phase 12024-10-29
CompletedStudy to Demonstrate Pharmacokinetic and Pharmacodynamic Similarity Between NKF-INS(A), US-NovoLog®, and EU-No
Healthy Participants
Phase 12024-07-30
CompletedSingle Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia®
Healthy Participants
Phase 12024-06-05
Enrolling By InvitationAn Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Pulmonary Sarcoidosis
Phase 22024-03-01
RecruitingA Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis
Pulmonary Sarcoidosis
Phase 1 / Phase 22023-11-10
CompletedSafety, Tolerability, and Pharmacokinetics of a Single Intravenous Infusion of XTMAB-16 in Healthy Adult Parti
Healthy Participants
Phase 12021-06-25